Suchergebnis | Hamburg Open Science

Facetten

38 Einträge gefunden

Circulating miRNAs are correlated with tumor progression in prostate cancer.
2011 - Forschungsinformationssystem des UKE
The novel nomogram of Gleason sum upgrade: possible application for the eligible criteria of low dose rate brachytherapy.
2010 - Forschungsinformationssystem des UKE
Partin Tables cannot accurately predict the pathological stage at radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
External validation of a preoperative nomogram for prediction of the risk of recurrence after radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Current Technique of Open Intrafascial Nerve-Sparing Retropubic Prostatectomy.
2009 - Forschungsinformationssystem des UKE
Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.
2009 - Forschungsinformationssystem des UKE
Effect of body mass index on histopathologic parameters: results of large European contemporary consecutive open radical prostatectomy series.
2009 - Forschungsinformationssystem des UKE
Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancer.
2009 - Forschungsinformationssystem des UKE
Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
[F(18)]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study.
2009 - Forschungsinformationssystem des UKE
Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
2008 - Forschungsinformationssystem des UKE
Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.
2008 - Forschungsinformationssystem des UKE
Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level
2008 - Forschungsinformationssystem des UKE
Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.
2008 - Forschungsinformationssystem des UKE
Development and external validation of an extended repeat biopsy nomogram.
2007 - Forschungsinformationssystem des UKE
Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.
2007 - Forschungsinformationssystem des UKE
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
2007 - Forschungsinformationssystem des UKE
Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.
2007 - Forschungsinformationssystem des UKE
Development and external validation of an extended 10-core biopsy nomogram.
2007 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Circulating miRNAs are correlated with tumor progression in prostate cancer.

The novel nomogram of Gleason sum upgrade: possible application for the eligible criteria of low dose rate brachytherapy.

Partin Tables cannot accurately predict the pathological stage at radical prostatectomy.

External validation of a preoperative nomogram for prediction of the risk of recurrence after radical prostatectomy.

Current Technique of Open Intrafascial Nerve-Sparing Retropubic Prostatectomy.

Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.

Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.

Effect of body mass index on histopathologic parameters: results of large European contemporary consecutive open radical prostatectomy series.

Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancer.

Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.

[F(18)]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study.

Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.

Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.

Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level

Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.

Development and external validation of an extended repeat biopsy nomogram.

Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.

Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.

Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.

Development and external validation of an extended 10-core biopsy nomogram.